4//SEC Filing
Lowdell Mark William 4
Accession 0001213900-24-044308
CIK 0001711754other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 4:08 PM ET
Size
5.6 KB
Accession
0001213900-24-044308
Insider Transaction Report
Form 4
Inmune Bio, Inc.INMB
Lowdell Mark William
Chief Scientific Officer
Transactions
- Award
Option (right to buy)
2024-05-14+100,000→ 100,000 totalExercise: $9.92Exp: 2034-05-13→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]Granted pursuant to the 2021 Stock Incentive Plan. One fourth (1/4) of the option will vest 12 months from the grant date and thereafter the remaining unvested option will become vested and exercisable on a monthly basis over three (3) years (1/36 per month) until the option is 100% vested which shall occur on the four-year anniversary of the grant date.
Documents
Issuer
Inmune Bio, Inc.
CIK 0001711754
Entity typeother
Related Parties
1- filerCIK 0001767037
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 4:08 PM ET
- Size
- 5.6 KB